Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cho Ee Ng

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|May 25, 2022
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Impact of Rome IV irritable bowel syndrome on work and activities of daily livingVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Neurogastroenterology and Motility|September 30, 2022
Willingness to pay for medications among patients with Rome IV Irritable Bowel SyndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and BurdenChristopher J Black, Cho-Ee Ng, Vivek C Goodoory, et al.
British Medical Bulletin|September 8, 2023
The future of clinical trials-is it virtual?Cho Ee Ng, Sarah Bowman, Jonathan Ling, et al.
Alimentary Pharmacology & Therapeutics|December 25, 2025
Stability of Classification Systems for Irritable Bowel SyndromeMais Khasawneh, Vivek C Goodoory, Cho Ee Ng, et al.
Neurogastroenterology and Motility|September 30, 2025
Epidemiology of Meal-Related Abdominal Discomfort or Pain in Irritable Bowel SyndromeMelanie S Cuffe, Vivek C Goodoory, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|May 25, 2022
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Impact of Rome IV irritable bowel syndrome on work and activities of daily livingVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Neurogastroenterology and Motility|September 30, 2022
Willingness to pay for medications among patients with Rome IV Irritable Bowel SyndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and BurdenChristopher J Black, Cho-Ee Ng, Vivek C Goodoory, et al.
British Medical Bulletin|September 8, 2023
The future of clinical trials-is it virtual?Cho Ee Ng, Sarah Bowman, Jonathan Ling, et al.
Alimentary Pharmacology & Therapeutics|December 25, 2025
Stability of Classification Systems for Irritable Bowel SyndromeMais Khasawneh, Vivek C Goodoory, Cho Ee Ng, et al.
Neurogastroenterology and Motility|September 30, 2025
Epidemiology of Meal-Related Abdominal Discomfort or Pain in Irritable Bowel SyndromeMelanie S Cuffe, Vivek C Goodoory, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Pageof 3